BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10576669)

  • 1. Reproducibility of microvessel counts in breast cancer specimens.
    Marson LP; Kurian KM; Miller WR; Dixon JM
    Br J Cancer; 1999 Nov; 81(6):1088-93. PubMed ID: 10576669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity and reproducibility of microvessel counts in breast cancer.
    de Jong JS; van Diest PJ; Baak JP
    Lab Invest; 1995 Dec; 73(6):922-6. PubMed ID: 8558855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of microvessel density in core needle biopsy specimen in breast cancer.
    Rydén L; Boiesen P; Jönsson PE
    Anticancer Res; 2004; 24(1):371-5. PubMed ID: 15015623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvessel density in core biopsies of prostatic adenocarcinoma: a stage predictor?
    Rogatsch H; Hittmair A; Reissigl A; Mikuz G; Feichtinger H
    J Pathol; 1997 Jun; 182(2):205-10. PubMed ID: 9274532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-quantitative RT-PCR assessment of molecular markers in breast large-core needle biopsies.
    Pohlodek K; Galbavý S; Bartosová M; Mucha V; Holomán K; Pastorek J; Pastoreková S
    Neoplasma; 2004; 51(6):415-21. PubMed ID: 15640949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis: a new prognostic marker for breast cancer.
    Magennis DP
    Br J Biomed Sci; 1998 Sep; 55(3):214-20. PubMed ID: 10367410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy and prognostic value of core biopsy in the management of breast cancer: a series of 542 patients.
    Richter-Ehrenstein C; Müller S; Noske A; Schneider A
    Int J Surg Pathol; 2009 Aug; 17(4):323-6. PubMed ID: 19029173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas.
    Acikalin MF; Oner U; Topçu I; Yaşar B; Kiper H; Colak E
    Dig Liver Dis; 2005 Mar; 37(3):162-9. PubMed ID: 15888280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
    Fox SB; Taylor M; Grøndahl-Hansen J; Kakolyris S; Gatter KC; Harris AL
    J Pathol; 2001 Sep; 195(2):236-43. PubMed ID: 11592104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast.
    Lee AH; Hodi Z; Ellis IO; Elston CW
    Histopathology; 2007 Sep; 51(3):336-44. PubMed ID: 17727475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic role of angiogenesis in breast cancer.
    Leek RD
    Anticancer Res; 2001; 21(6B):4325-31. PubMed ID: 11908687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients.
    Hansen S; Grabau DA; Sørensen FB; Bak M; Vach W; Rose C
    Clin Cancer Res; 2000 Jan; 6(1):139-46. PubMed ID: 10656442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients.
    Hansen S; Sørensen FB; Vach W; Grabau DA; Bak M; Rose C
    Histopathology; 2004 May; 44(5):428-36. PubMed ID: 15139990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer.
    Su MY; Cheung YC; Fruehauf JP; Yu H; Nalcioglu O; Mechetner E; Kyshtoobayeva A; Chen SC; Hsueh S; McLaren CE; Wan YL
    J Magn Reson Imaging; 2003 Oct; 18(4):467-77. PubMed ID: 14508784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer.
    Mann GB; Fahey VD; Feleppa F; Buchanan MR
    J Clin Oncol; 2005 Aug; 23(22):5148-54. PubMed ID: 16051956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvessel density for melanoma prognosis.
    Depasquale I; Thompson WD
    Histopathology; 2005 Aug; 47(2):186-94. PubMed ID: 16045780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopsy findings after breast conservation therapy for early-stage invasive breast cancer.
    Vapiwala N; Starzyk J; Harris EE; Tchou JC; Boraas MC; Czerniecki BJ; Rosato EF; Orel SG; Solin LJ
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):490-7. PubMed ID: 17544594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing microvessels and angiogenesis in human breast cancer, using VE-cadherin.
    Martin TA; Watkins G; Lane J; Jiang WG
    Histopathology; 2005 Apr; 46(4):422-30. PubMed ID: 15810954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer.
    Sullivan CA; Ghosh S; Ocal IT; Camp RL; Rimm DL; Chung GG
    Hum Pathol; 2009 Feb; 40(2):156-65. PubMed ID: 18799189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.